Page last updated: 2024-10-31

midodrine and Erythermalgia

midodrine has been researched along with Erythermalgia in 1 studies

Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MD1
Morr, CS1
Warndahl, RA1
Sandroni, P1

Other Studies

1 other study available for midodrine and Erythermalgia

ArticleYear
Topically Applied Midodrine, 0.2%, an α1-Agonist, for the Treatment of Erythromelalgia.
    JAMA dermatology, 2015, Volume: 151, Issue:9

    Topics: Administration, Topical; Adrenergic alpha-1 Receptor Agonists; Adult; Aged; Diagnosis, Differential;

2015